REVVITY, INC Revenue
REVVITY, INC (RVTY) reported Revenue of $729.69 million for the 3-month period ending 2026-07-05, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-11
- REVVITY, INC revenue from contract with customer, excluding assessed tax for the quarter ending 2026-07-05 was $729.69M, a 1.31% increase year-over-year.
- REVVITY, INC revenue from contract with customer, excluding assessed tax for the quarter ending 2026-04-05 was $711.12M, a 6.97% increase year-over-year.
- REVVITY, INC revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-28 was $772.06M, a 5.85% increase year-over-year.
- REVVITY, INC revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-28 was $698.95M, a 2.18% increase year-over-year.
- REVVITY, INC revenue from contract with customer, excluding assessed tax for fiscal 2025 was $2.86B, a 3.67% increase from fiscal 2024.
- REVVITY, INC revenue from contract with customer, excluding assessed tax for fiscal 2024 was $2.76B, a 0.16% increase from fiscal 2023.
- REVVITY, INC revenue from contract with customer, excluding assessed tax for fiscal 2023 was $2.75B, a 16.95% decline from fiscal 2023.
- REVVITY, INC revenue from contract with customer, excluding assessed tax for fiscal 2023 was $3.31B, a 13.48% decline from fiscal 2022.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 12 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-07-05 | $729.69M 10-Q · filed 2026-08-11 | $1.44B 10-Q · filed 2026-08-11 | $2.21B derived: sum of 3 quarters · filed 2026-08-11 | $2.91B derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-04-05 | $711.12M 10-Q · filed 2026-05-12 | $1.48B derived: sum of 2 quarters · filed 2026-05-12 | $2.18B derived: sum of 3 quarters · filed 2026-05-12 | $2.90B derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-28 | $772.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.47B derived: sum of 2 quarters · filed 2026-02-24 | $2.19B derived: sum of 3 quarters · filed 2026-08-11 | $2.86B 10-K · filed 2026-02-24 | ||||
| 2025-09-28 | $698.95M 10-Q · filed 2025-11-04 | $1.42B derived: sum of 2 quarters · filed 2026-08-11 | $2.08B 10-Q · filed 2025-11-04 | $2.81B derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-29 | $720.28M 10-Q · filed 2026-08-11 | $1.39B 10-Q · filed 2026-08-11 | $2.11B derived: sum of 3 quarters · filed 2026-08-11 | $2.80B derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-30 | $664.76M 10-Q · filed 2026-05-12 | $1.39B derived: sum of 2 quarters · filed 2026-05-12 | $2.08B derived: sum of 3 quarters · filed 2026-05-12 | $2.77B derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-29 | $729.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.41B derived: sum of 2 quarters · filed 2026-02-24 | $2.11B derived: sum of 3 quarters · filed 2026-02-24 | $2.76B 10-K · filed 2026-02-24 | ||||
| 2024-09-29 | $684.05M 10-Q · filed 2025-11-04 | $1.38B derived: sum of 2 quarters · filed 2025-11-04 | $2.03B 10-Q · filed 2025-11-04 | $2.72B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $691.68M 10-Q · filed 2025-08-05 | $1.34B 10-Q · filed 2025-08-05 | $2.04B derived: sum of 3 quarters · filed 2026-02-24 | $2.71B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $649.92M 10-Q · filed 2025-05-06 | $1.35B derived: sum of 2 quarters · filed 2026-02-24 | $2.02B derived: sum of 3 quarters · filed 2026-02-24 | $2.73B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $695.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.37B derived: sum of 2 quarters · filed 2026-02-24 | $2.08B derived: sum of 3 quarters · filed 2026-02-24 | $2.75B 10-K · filed 2026-02-24 | ||||
| 2023-10-01 | $670.74M 10-Q · filed 2024-11-06 | $1.38B derived: sum of 2 quarters · filed 2024-11-06 | $2.05B 10-Q · filed 2024-11-06 | $2.80B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-07-02 | $709.07M 10-Q · filed 2024-08-06 | $1.38B 10-Q · filed 2024-08-06 | $2.13B derived: sum of 3 quarters · filed 2025-02-25 | $2.84B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-04-02 | $674.87M 10-Q · filed 2024-05-07 | $1.42B derived: sum of 2 quarters · filed 2025-02-25 | $2.13B derived: sum of 3 quarters · filed 2025-02-25 | $3.02B derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-01-01 | $741.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $1.45B derived: sum of 2 quarters · filed 2025-02-25 | $2.35B derived: sum of 3 quarters · filed 2025-02-25 | $3.31B 10-K · filed 2025-02-25 | ||||
| 2022-10-02 | $711.80M 10-Q · filed 2023-11-07 | $1.61B derived: sum of 2 quarters · filed 2023-11-07 | $2.57B 10-Q · filed 2023-11-07 | $3.60B derived: sum of 4 quarters · filed 2024-02-27 | ||||
| 2022-07-03 | $895.64M 10-Q · filed 2023-08-09 | $1.23B 10-Q · filed 2022-08-09 | $1.86B 10-Q · filed 2023-08-09 | $2.49B 10-Q · filed 2022-08-09 | $2.89B derived: sum of 3 quarters · filed 2024-02-27 | $3.75B derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-04-03 | $963.16M 10-Q · filed 2023-05-12 | $1.26B 10-Q · filed 2022-05-10 | $1.99B derived: sum of 2 quarters · filed 2024-02-27 | $2.85B derived: sum of 3 quarters · filed 2024-02-27 | $4.08B derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2022-01-02 | $1.03B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.89B derived: sum of 2 quarters · filed 2024-02-27 | $3.12B derived: sum of 3 quarters · filed 2024-02-27 | $3.83B 10-K · filed 2024-02-27 | $5.07B 10-K · filed 2022-03-03 | |||
| 2021-10-03 | $861.32M 10-Q · filed 2022-11-14 | $1.17B 10-Q · filed 2021-11-09 | $2.09B derived: sum of 2 quarters · filed 2022-11-14 | $2.80B 10-Q · filed 2022-11-14 | $3.70B 10-Q · filed 2021-11-09 | $3.63B derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-07-04 | $1.23B 10-Q · filed 2022-08-09 | $2.54B 10-Q · filed 2022-08-09 | $2.77B derived: sum of 3 quarters · filed 2023-03-01 | $3.74B derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-04-04 | $1.31B 10-Q · filed 2022-05-10 | $1.54B derived: sum of 2 quarters · filed 2023-03-01 | $2.51B derived: sum of 3 quarters · filed 2023-03-01 | $3.32B derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-01-03 | $235.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.20B derived: sum of 2 quarters · filed 2023-03-01 | $2.01B derived: sum of 3 quarters · filed 2023-03-01 | $2.66B 10-K · filed 2023-03-01 | $3.78B 10-K · filed 2021-03-02 | |||
| 2020-10-04 | $964.02M 10-Q · filed 2021-11-09 | $1.78B derived: sum of 2 quarters · filed 2021-11-09 | $2.43B 10-Q · filed 2021-11-09 | $3.23B derived: sum of 4 quarters · filed 2022-03-03 | ||||
| 2020-07-05 | $811.72M 10-Q · filed 2021-08-10 | $1.46B 10-Q · filed 2021-08-10 | $2.27B derived: sum of 3 quarters · filed 2022-03-03 | $2.98B derived: sum of 4 quarters · filed 2022-03-03 | ||||
| 2020-04-05 | $652.40M 10-Q · filed 2021-05-11 | $1.46B derived: sum of 2 quarters · filed 2022-03-03 | $2.16B derived: sum of 3 quarters · filed 2022-03-03 | $2.89B derived: sum of 4 quarters · filed 2022-03-03 | ||||
| 2019-12-29 | $805.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $1.51B derived: sum of 2 quarters · filed 2022-03-03 | $2.23B derived: sum of 3 quarters · filed 2022-03-03 | $2.88B 10-K · filed 2022-03-03 | ||||
| 2019-09-29 | $706.92M 10-Q · filed 2020-11-10 | $1.43B derived: sum of 2 quarters · filed 2020-11-10 | $2.08B 10-Q · filed 2020-11-10 | $2.83B derived: sum of 4 quarters · filed 2021-03-02 | ||||
| 2019-06-30 | $722.52M 10-Q · filed 2020-08-11 | $1.37B 10-Q · filed 2020-08-11 | $2.13B derived: sum of 3 quarters · filed 2021-03-02 | $2.80B derived: sum of 4 quarters · filed 2021-03-02 | ||||
| 2019-03-31 | $648.74M 10-Q · filed 2020-05-12 | $1.41B derived: sum of 2 quarters · filed 2021-03-02 | $2.08B derived: sum of 3 quarters · filed 2021-03-02 | $2.78B derived: sum of 4 quarters · filed 2021-03-02 | ||||
| 2018-12-30 | $756.35M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $1.43B derived: sum of 2 quarters · filed 2021-03-02 | $2.13B derived: sum of 3 quarters · filed 2021-03-02 | $2.78B 10-K · filed 2021-03-02 | ||||
| 2018-09-30 | $674.31M 10-Q · filed 2019-11-05 | $1.38B derived: sum of 2 quarters · filed 2019-11-05 | $2.02B 10-Q · filed 2019-11-05 | $2.66B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-07-01 | $703.36M 10-Q · filed 2019-08-06 | $1.35B 10-Q · filed 2019-08-06 | $1.99B derived: sum of 3 quarters · filed 2020-02-25 | $2.54B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-04-01 | $643.97M 10-Q · filed 2019-05-07 | $1.29B derived: sum of 2 quarters · filed 2020-02-25 | $1.84B derived: sum of 3 quarters · filed 2020-02-25 | $2.39B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | $641.63M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $1.20B derived: sum of 2 quarters · filed 2020-02-25 | $1.74B derived: sum of 3 quarters · filed 2020-02-25 | $2.26B 10-K · filed 2020-02-25 | ||||
| 2017-10-01 | $554.27M 10-Q · filed 2018-11-06 | $1.10B derived: sum of 2 quarters · filed 2018-11-06 | $1.62B 10-Q · filed 2018-11-06 | |||||
| 2017-07-02 | $546.96M 10-Q · filed 2018-08-07 | $1.06B 10-Q · filed 2018-08-07 | ||||||
| 2017-01-01 | $2.12B 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |